Race to stop deadly bleeding after birth: two drugs face off
NCT ID NCT07353281
Summary
This study aims to find the better medication to prevent dangerous bleeding after vaginal delivery in women at higher risk. Researchers will compare carbetocin (given by IV) with misoprostol (given rectally) in 146 women at Galilee Medical Center. The main goal is to see which drug more effectively prevents severe blood loss and reduces the need for extra treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POSTPARTUM COMPLICATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.